These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 19661939

  • 21. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
    Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ.
    Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
    [Abstract] [Full Text] [Related]

  • 22. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F, Frigo AC, Fazio V, Marabotto E, Savarino V.
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [Abstract] [Full Text] [Related]

  • 23. Azathioprine for prevention of postoperative recurrence in Crohn's disease.
    Travis S.
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1277-9. PubMed ID: 11692049
    [Abstract] [Full Text] [Related]

  • 24. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P, Reinisch W, Ho E, Gratzer C, Lissner D, Herkner H, Riss S, Dejaco C, Miehsler W, Vogelsang H, Novacek G.
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [Abstract] [Full Text] [Related]

  • 25. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P, Hinojosa J, Aguilera V, Molés JR, Pastor M, Ponce J, Berenguer J.
    Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 28. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 29. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

  • 30. Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification.
    Guo J, Chen BL, Chen ZH, Luo XP, Qiu Y, Zhang SH, Feng R, He Y, Zeng ZR, Song XM, Ben-Horin S, Mao R, Chen MH.
    J Gastroenterol Hepatol; 2018 Mar; 33(3):608-614. PubMed ID: 28804920
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Ford AC.
    Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
    [No Abstract] [Full Text] [Related]

  • 32. [Azathioprine for prevention of postoperative recurrence in Crohn's disease].
    Abdelli MN, Ben Abdallah H, Houissa F, Bouali MR, Khediri MF.
    Tunis Med; 2007 Jul; 85(7):569-72. PubMed ID: 18064988
    [Abstract] [Full Text] [Related]

  • 33. Maintenance treatment for Crohn's disease: has the time arrived?
    Goldstein F.
    Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
    [No Abstract] [Full Text] [Related]

  • 34. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
    Magro F, Santos-Antunes J, Vilas-Boas F, Rodrigues-Pinto E, Coelho R, Ribeiro OS, Lopes S, Macedo G.
    J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Reinisch W, Stange EF, International AZT-2 Study Group.
    Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
    [No Abstract] [Full Text] [Related]

  • 36. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH.
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [Abstract] [Full Text] [Related]

  • 37. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
    Myrelid P, Svärm S, Andersson P, Almer S, Bodemar G, Olaison G.
    Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204
    [Abstract] [Full Text] [Related]

  • 38. [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
    Domènech E, Scala L, Bernal I, García-Planella E, Casalots A, Piñol M, Esteve-Comas M, Cabré E, Boix J, Gassull MA.
    Gastroenterol Hepatol; 2004 Dec; 27(10):563-7. PubMed ID: 15574279
    [Abstract] [Full Text] [Related]

  • 39. Protagonist: Crohn's disease recurrence can be prevented after ileal resection.
    Rutgeerts P.
    Gut; 2002 Aug; 51(2):152-3. PubMed ID: 12117870
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):614-20. PubMed ID: 19552632
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.